Latest Regulatory News

Page 259 of 890
Yancoal has reported record coal production and sales for 2025, achieving near the top of its guidance range with improved realised prices despite challenging market conditions. The company’s robust cash position and disciplined cost management position it well for future growth.
Maxwell Dee
Maxwell Dee
19 Jan 2026
Richmond Vanadium Technology Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, confirming no undisclosed information is driving the activity and attributing the surge to broader market interest and improved liquidity.
Maxwell Dee
Maxwell Dee
19 Jan 2026
AuKing Mining reports promising exploration results at Myoff Creek and steady progress at Koongie Park, while grappling with a failed Cloncurry acquisition and significant board changes.
Maxwell Dee
Maxwell Dee
19 Jan 2026
The a2 Milk Company has responded to an ASX price query denying any undisclosed information behind recent share price moves, attributing the volatility to China’s latest birth statistics.
Victor Sage
Victor Sage
19 Jan 2026
Phoslock Environmental Technologies has amended its December 2025 quarterly report to correct funding data and withdraw its sales outlook, while reporting improved cash flow and resuming factory operations.
Maxwell Dee
Maxwell Dee
19 Jan 2026
Alice Queen Limited (AQX) has had its trading suspension lifted immediately following its response to an ASX Price Query, reopening access for investors.
Victor Sage
Victor Sage
19 Jan 2026
Arena REIT has announced an ordinary quarterly dividend of AUD 0.048125 per security, payable on 5 February 2026, alongside a Dividend Reinvestment Plan priced at AUD 3.50330, offering investors a 1.5% discount.
Victor Sage
Victor Sage
19 Jan 2026
DXN Limited has signed a strategic MOU with Super Sistem Indonesia to form a joint venture targeting Indonesia’s rapidly expanding digital infrastructure market, aiming for US$7 million in revenue over three years.
Sophie Babbage
Sophie Babbage
19 Jan 2026
Mesoblast has received encouraging feedback from the FDA on its cell therapy rexlemestrocel-L, showing meaningful pain relief and potential opioid use reduction in chronic low back pain patients. The company’s ongoing Phase 3 trial aims to confirm these benefits and advance regulatory approval.
Ada Torres
Ada Torres
19 Jan 2026
Nickel Industries faced a challenging December quarter due to delayed regulatory approvals impacting ore sales, yet the company kicked off 2026 with robust nickel ore sales and record earnings from its HPAL project.
Maxwell Dee
Maxwell Dee
19 Jan 2026
Riversgold Limited reports encouraging shallow gold intersections at its Northern Zone Gold Project near Kalgoorlie, supported by a $2.15 million capital raise with MEGA Resources as a key investor. The drilling results and strategic partnership set the stage for advancing mining plans in 2026.
Maxwell Dee
Maxwell Dee
19 Jan 2026
Jupiter Energy reported steady oil production and US$1.6 million in domestic sales for Q4 2025, while completing integration of its West Zhetybai oilfield into a regional gas utilisation network.
Maxwell Dee
Maxwell Dee
19 Jan 2026